Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry|October 2, 2017
Bifunctional aryliodonium salts for highly efficient radioiodination and astatination of antibodiesF Guérard, L Navarro, Y-S Lee, et al.
Analytica Chimica Acta|March 13, 2012
Characterization of At- species in simple and biological media by high performance anion exchange chromatography coupled to gamma detectorA Sabatié-Gogova, J Champion, S Huclier, et al.
Radiation Research|July 8, 2009
Evidence of extranuclear cell sensitivity to alpha-particle radiation using a microdosimetric model. I. Presentation and validation of a microdosimetric modelN Chouin, K Bernardeau, F Davodeau, et al.
Radiation Research|July 8, 2009
Evidence of extranuclear cell sensitivity to alpha-particle radiation using a microdosimetric model. II. Application of the microdosimetric model to experimental resultsN Chouin, K Bernardeau, M Bardiès, et al.
Veterinary and Comparative Oncology|April 15, 2016
Production and characterization of monoclonal antibodies specific for canine CD138 (syndecan-1) for nuclear medicine preclinical trials on spontaneous tumoursM Diab, F Nguyen, M Berthaud, et al.
Nuclear Medicine and Biology|April 25, 2014
Comparative analysis of multiple myeloma treatment by CD138 antigen targeting with bismuth-213 and Melphalan chemotherapyS Gouard, A Pallardy, J Gaschet, et al.
The Journal of Biological Chemistry|June 20, 1998
Cotranscription and intergenic splicing of human galactose-1-phosphate uridylyltransferase and interleukin-11 receptor alpha-chain genes generate a fusion mRNA in normal cells. Implication for the production of multidomain proteins during evolutionF Magrangeas, G Pitiot, S Dubois, et al.
Oncoimmunology|July 9, 2021
Anti-tumor efficacy of a combination therapy with PD-L1 targeted alpha therapy and adoptive cell transfer of PD-1 deficient melanoma-specific human T-lymphocytesL Marotte, M Capitao, C Deleine, et al.
FEBS Letters|April 28, 1997
Reconstitution of two isoforms of the human interleukin-11 receptor and comparison of their functional propertiesB Lebeau, F A Montero Julian, J Wijdenes, et al.
Genomics|January 7, 1998
Construction of a 780-kb PAC, BAC, and cosmid contig encompassing the minimal critical deletion involved in B cell chronic lymphocytic leukemia at 13q14.3I Bouyge-Moreau, G Rondeau, H Avet-Loiseau, et al.
Pageof 3